For years, the default definitive treatment ... The most recent NCCN guidelines align with Flores’ take. The guidelines say that SBRT is indicated for stage IA-IIA (N0) NSCLC in patients who ...

Q1 2025 Management View Executive Chairman Bill Doyle highlighted the company’s transition to a multi-indication oncology company, emphasizing the regulatory and commercial advancements. He announced ...

While surgery has been a primary treatment option for some early-stage NSCLC patients, recurrence rates of 30% to 55% highlight the need for additional perioperative interventions. “Given the ...

AstraZeneca’s efforts to move its top oncology drugs into earlier treatment settings ... in patients with early-stage, EGFR-mutated non-small cell lung cancer (NSCLC) after surgery intending ...

A new study published in The Annals of Thoracic Surgery suggests that Medicaid expansion under the Affordable Care Act has ...

They do this for a few reasons: One treatment alone may not make the cancer shrink or go away. Adding one makes the original work better. Certain treatments work better at different stages of your ...

If you have metastatic non-small-cell lung cancer (NSCLC), you might wonder if the treatment plan that your doctor recommended is the best one for you. Metastatic NSCLC is “stage IV” or ...

For early-stage non-small cell lung cancer (NSCLC), the most common type of lung cancer, the mainstay treatment is video-assisted thoracoscopic lobectomy — the anatomic resection of an entire ...

Taiwan’s health authority on Thursday said it has plans to expand existing National Health Insurance (NHI) coverage to ...

Deferring upfront CNS-directed radiation in EGFR-variant and ALK-positive NSCLC may improve outcomes but raises treatment-related toxicity risks.